default author photo

Rosnawati Yahya

Hospital Kuala Lumpur

Dept of Nephrology

Jalan Pahang

Kuala Lumpur, 50586

Malaysia

  • Hospital Kuala Lumpur

SCHOLARLY PAPERS

1

DOWNLOADS

124

TOTAL CITATIONS

1

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Safety, Immunogenicity, and Efficacy of Recombinant COVID-19 Inhalation Vaccine (Adenovirus Type 5 Vector) as Second Booster Dose Against Emerging Variants of Concern (VOC) of SARS-CoV-2 to Prevent Breakthrough Infections: An Observer-Blinded, Randomised, Phase 3, Non-Inferiority Trial

Number of pages: 31 Posted: 18 Mar 2024
Chun Keat Chew, Ruijie Wang, Sunita Bavanandan, Norliza Zainudin, Xiaoyuan Zhao, Sumeyya Ahmed, Damenthi Nair, Li-Hua Hou, Rosnawati Yahya, Shereen Suyin Ch'ng, Lai Hui Pang, Azrini Abdul Aziz, Hai-Tao Huang, Reena Rajasuriar, Shi-Po Wu, Zhe Zhang, Xuewen Wang, Tao Zhu, Teck Onn Lim, Jin-Bo Gou, Sharon Shi Min Ng and CoVaxBooster Study Group
Institute for Clinical Research, CanSino Biologics Inc., Hospital Kuala Lumpur, Selayang Hospital, CanSino Biologics Inc., CanSino Biologics Inc., Institute for Clinical Research, Academy of Military Medical Sciences - Institute of Biotechnology, Hospital Kuala Lumpur, Selayang Hospital, Institute for Clinical Research, Hospital Kuala Lumpur, CanSino Biologics Inc., University of Malaya (UM), Academy of Military Medical Sciences - Institute of Biotechnology, Academy of Military Medical Sciences - Institute of Biotechnology, CanSino Biologics Inc., CanSino Biologics Inc., Clin Research Private Enterprise, CanSino Biologics Inc., Institute for Clinical Research and Independent
Downloads 124 (580,653)
Citation 1

Abstract:

Loading...

COVID-19 vaccines, inhaled vaccines, immunogenicity, SARS-CoV-2, Ad5-CoV, aerosol inhalation, booster